During the past decade, OptumCare Cancer Care at MountainView conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 15 clinical trials were completed, i.e. on average, 13.2% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 15 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OptumCare Cancer Care at MountainView" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OptumCare Cancer Care at MountainView" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "OptumCare Cancer Care at MountainView" are "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IIIA Breast Cancer" (5 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "OptumCare Cancer Care at MountainView" in a lesser frequency.

Most popular intervention types in "OptumCare Cancer Care at MountainView" are "Drug" (92 trials), "Other" (68 trials), "Biological" (54 trials), "Procedure" (45 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (33 trials), "Computed Tomography" (30 trials), "Biospecimen Collection" (27 trials), "Questionnaire Administration" (26 trials) and "Nivolumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "OptumCare Cancer Care at MountainView" are 107 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "OptumCare Cancer Care at MountainView". undefined are not yet recruiting, 47 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in OptumCare Cancer Care at MountainView, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in OptumCare Cancer Care at MountainView, 3 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".